Volume 11, Number 11—November 2005
Letter
Staphylococcus aureus Bacteremia, Europe
Table
Country | Population† (4) | % population covered by EARSS‡ | Blood culture sets/1,000 inhabitants | No. SAB reported to EARSS | No. SAB for country§ | SAB/100,000 inhabitants§ | % MRSA |
---|---|---|---|---|---|---|---|
Austria | 8,188,207 | 42.7 | NA | 871 | 2,038 | 25 | 15 |
Bulgaria | 7,537,929 | 100 | 2 | 157 | 149 | 2¶ | 31 |
Croatia | 4,422,248 | 81.3 | 7 | 360 | 443 | 10 | 37 |
Czech Republic | 10,249,216 | 92.3 | 11 | 1,387 | 1,503 | 15 | 7 |
Denmark | 5,384,384 | 46.2 | NA | 671 | 1,451 | 27 | <1 |
Estonia | 1,408,556 | 100 | <1 | 98 | 98 | 7¶ | 5 |
Finland | 5,190,785 | 94.3 | 27 | 727 | 771 | 15 | 1 |
Hungary | 10,045,407 | 100 | 1 | 859 | 859 | 9¶ | 14 |
Iceland | 280,798 | 100 | 28 | 64 | 64 | 23 | 0 |
Ireland | 3,924,140 | 89.2 | NA | 1,108 | 1,243 | 32 | 42 |
Israel | 6,116,533 | 39.7 | 42 | 368 | 926 | 15 | 43 |
Malta | 400,420 | 100 | 4 | 122 | 122 | 31 | 43 |
Poland | 38,622,660 | 24.3 | 3 | 166 | 684 | 2¶ | 19 |
Romania | 22,271,839 | 59 | <1 | 85 | 144 | <1¶ | 46 |
Slovenia | 1,935,677 | 100 | 17 | 299 | 296 | 15 | 13 |
Spain | 40,217,413 | 24.3 | 21 | 1,391 | 5,731 | 14 | 25 |
Sweden | 8,878,085 | 100 | 28 | 1,855 | 1,760 | 20 | <1 |
*Only countries that provided hospital background information for at least 60% of the isolates were included; NA, not available.
†Source (4).
‡Population coverage rate as calculated from EARSS hospitals that provided background information was adjusted for nonresponding hospitals as follows: population coverage as calculated divided by proportion of isolates with hospital background information.
§The total number of SAB per country was calculated as follows: number of S. aureus isolates in EARSS divided by adjusted proportion of population covered.
¶These rates are grossly underestimated because of the very low blood culturing rate.
References
- Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis. 2005;11:554–61.PubMedGoogle Scholar
- Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis. 2004;10:1627–34.PubMedGoogle Scholar
- European Antimicrobial Resistance Surveillance System. EARSS manual 2004 [cited 2005 July 25]. Available from http://www.earss.rivm.nl
- Central Intelligence Agency. The world fact book 2003 [cited 2005 July 26]. Available from http://www.cia.gov/cia/download2003.htm
- Health Protection Agency. The second year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute trusts in England: April 2002–March 2003. CDR Weekly. 2003;13:1–9. [cited 2005 July 26]. Available from http://www.hpa.org.uk/cdr/archives/2003/cdr2503.pdf
Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.